FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Haanen

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Disorders

Procedures

Co-author Network

Publications

TOP 3
Bernies van der Hiel; Christian U Blank; John B A G Haanen; Marcel P M Stokkel
Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab.
E H J G Aarntzen; Gosse J Adema; Willeke A M Blokx; Kalijn Bol; Alexandra J Croockewit; I Jolanda M De Vries; Johannes H W de Wilt; John B A G Haanen; J F M Jacobs; William W Kwok; W Joost Lesterhuis; Roel Mus; Cornelis J A Punt; Dirk Schadendorf; Gerty Schreibelt; Danita Schuurhuis; Michelle M van Rossum; Carl G Figdor
Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
Silvia Ariotti; Joost B Beltman; Grzegorz Chodaczek; Rob J De Boer; Raquel Gomez-Eerland; John B A G Haanen; Mirjam E Hoekstra; Athanasius F M Marée; Laila Ritsma; Anna E van Beek; Jacco van Rheenen; Tomasz Zal; Ton N Schumacher
Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Haanen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bernies van der Hiel; Christian U Blank; John B A G Haanen; Marcel P M Stokkel
Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab.
Clinical nuclear medicine 2013;38(4):e182-4.
2013: E H J G Aarntzen; Gosse J Adema; Willeke A M Blokx; Kalijn Bol; Alexandra J Croockewit; I Jolanda M De Vries; Johannes H W de Wilt; John B A G Haanen; J F M Jacobs; William W Kwok; W Joost Lesterhuis; Roel Mus; Cornelis J A Punt; Dirk Schadendorf; Gerty Schreibelt; Danita Schuurhuis; Michelle M van Rossum; Carl G Figdor
Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
Cancer research 2013;73(1):19-29.
2012: Silvia Ariotti; Joost B Beltman; Grzegorz Chodaczek; Rob J De Boer; Raquel Gomez-Eerland; John B A G Haanen; Mirjam E Hoekstra; Athanasius F M Marée; Laila Ritsma; Anna E van Beek; Jacco van Rheenen; Tomasz Zal; Ton N Schumacher
Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(48):19739-44.
2012: Astrid A M van der Veldt; Victor W M van Hinsbergh; Laura Vroling; Henk J Broxterman; Richard R de Haas; John B A G Haanen; PIETER KOOLWIJK; Alfons J M van den Eertwegh; Epie Boven
Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer.
International journal of cancer. Journal international du cancer 2012;131(4):E484-93.
2012: Saskia A M van de Schans; Carla van Herpen; Rob Verhoeven; Peter F A Mulders; Egbert Oosterwijk; Katja K H Aben; John B A G Haanen; Henrike E Karim-Kos; Lambertus A L M Kiemeney
Modest improvement in 20 years of kidney cancer care in the Netherlands.
European journal of cancer (Oxford, England : 1990) 2012;48(12):1822-30.
2012: F E Henken; Erik Hooijberg; K Oosterhuis; L Bosch; John B A G Haanen; Peter Ohlschläger; Renske D M Steenbergen
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
Vaccine 2012;30(28):4259-66.
2012: K Oosterhuis; Schumacher Ton; J H van den Berg; John B A G Haanen
DNA vaccines and intradermal vaccination by DNA tattooing.
Current topics in microbiology and immunology 2012;351():221-50.
2011: Christian U Blank; John B A G Haanen; Anna I Hooijkaas; Ton N Schumacher
Combination of targeted therapy and immunotherapy in melanoma.
Cancer immunology, immunotherapy : CII 2011;60(10):1359-71.
2011: Esther P M Tjin; Chantal M A M van der Horst; Florry A Vyth-Dreese; Henk Mallo; Cornelis J M Melief; Omgo E Nieweg; Jan D Bos; Jan W Drijfhout; Kees L M C Franken; John B A G Haanen; Debby Konijnenberg; Gabrielle Krebbers; Bin B R Kroon; Rosalie M Luiten
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(17):5736-47.
2011: Koen Oosterhuis; Ton N Schumacher; Mireille Toebes; Joost H van den Berg; Raquel Gomez; Peter Ohlschläger; John B A G Haanen
Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.
International journal of cancer. Journal international du cancer 2011;129(2):397-406.
2011: Els Verdegaal; Marten Visser; John B A G Haanen; Ellen Kapiteijn; Johan W R Nortier; Tamara H Ramwadhdoebé; Sjoerd H van der burg; Caroline E van der Minne; Jeanne A Q M J van Steijn; Susanne Osanto
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
Cancer immunology, immunotherapy : CII 2011;60(7):953-63.
2011: Astrid A M van der Veldt; Karel Eechoute; Hans Gelderblom; Jourik Gietema; Henk-Jan Guchelaar; Nielka P H van Erp; Alfons J M van den Eertwegh; John B A G Haanen; Ron H J Mathijssen; Judith A M Wessels
Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(3):620-9.
2010: Florry A Vyth-Dreese; Johan Sein; Willeke F van de Kasteele; T A M Dellemijn; C van den Bogaard; W J Nooijen; Gijsbert C De Gast; John B A G Haanen; A Bex
Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.
Clinical and experimental immunology 2010;162(3):447-59.
2010: Astrid A M van der Veldt; John B A G Haanen; Alfons J M van den Eertwegh; Epie Boven
Targeted therapy for renal cell cancer: current perspectives.
Discovery medicine 2010;10(54):394-405.
2010: Bianca Heemskerk; Annelies Jorritsma; Raquel Gomez-Eerland; Mireille Toebes; John B A G Haanen; Schumacher Ton
Microbead-assisted retroviral transduction for clinical application.
Human gene therapy 2010;21(10):1335-42.
2010: Joost H van den Berg; Koen Oosterhuis; Jos H Beijnen; Bastiaan Nuijen; John B A G Haanen
DNA vaccination in oncology: current status, opportunities and perspectives.
Current clinical pharmacology 2010;5(3):218-25.
2010: Lisa Borkner; Andrew Kaiser; Willeke van de Kasteele; Reinhard Andreesen; Andreas Mackensen; John B A G Haanen; Schumacher Ton; Christian Blank
RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells.
Cancer immunology, immunotherapy : CII 2010;59(8):1173-83.
2010: Joost H van den Berg; Susanne G L Quaak; Jos H Beijnen; Wim E Hennink; Gert Storm; Ton N Schumacher; John B A G Haanen; Bastiaan Nuijen
Lipopolysaccharide contamination in intradermal DNA vaccination: toxic impurity or adjuvant?
International journal of pharmaceutics 2010;390(1):32-6.
2010: Gavin M Bendle; Carsten Linnemann; Anna I Hooijkaas; Laura Bies; Moniek A de Witte; Annelies Jorritsma; Andrew Kaiser; Nadine Pouw; Reno Debets; Elisa Kieback; Wolfgang Uckert; Ji-Ying Song; John B A G Haanen; Schumacher Ton
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.
Nature medicine 2010;16(5):565-70, 1p following 570.
2010: Axel Bex; Astrid A M van der Veldt; Christian Blank; Martijn R Meijerink; Epie Boven; John B A G Haanen
Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
Acta oncologica (Stockholm, Sweden) 2010;49(4):520-3.
2010: Axel Bex; Astrid A M van der Veldt; Epie Boven; John B A G Haanen
Re: Surgical resection of renal cell carcinoma after targeted therapyA. A. Thomas, B. I. Rini, A. J. Stephenson, J. A. Garcia, A. Fergany, V. Krishnamurthi, A. C. Novick, I. S. Gill, E. A. Klein, M. Zhou and S. C. Campbell J Urol 2009; 182: 881-886.
The Journal of urology 2010;183(4):1646-7; author reply 1647.
2010: Astrid A M van der Veldt; M R Meijerink; Alfons J M van den Eertwegh; John B A G Haanen; Epie Boven
Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
British journal of cancer 2010;102(5):803-9.
2010: Susanne G L Quaak; John B A G Haanen; Jos H Beijnen; Bastiaan Nuijen
Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisation.
AAPS PharmSciTech 2010;11(1):344-50.
2010: Joost H van den Berg; Koen Oosterhuis; Wim E Hennink; Gert Storm; Hans van der Aa; Johan F J Engbersen; John B A G Haanen; Jos H Beijnen; Ton N Schumacher; Bastiaan Nuijen
Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity.
Journal of controlled release : official journal of the Controlled Release Society 2010;141(2):234-40.
2010: Joost H van den Berg; Bastiaan Nuijen; Ton N Schumacher; John B A G Haanen; Gert Storm; Jos H Beijnen; Wim E Hennink
Synthetic vehicles for DNA vaccination.
Journal of drug targeting 2010;18(1):1-14.
2009: S G L Quaak; J H van den Berg; K Oosterhuis; Jos H Beijnen; John B A G Haanen; Bastiaan Nuijen
DNA tattoo vaccination: effect on plasmid purity and transfection efficiency of different topoisoforms.
Journal of controlled release : official journal of the Controlled Release Society 2009;139(2):153-9.
2009: Judith Y M N Engwegen; Niven Mehra; John B A G Haanen; Jan H M Schellens; Emile E Voest; Jos H Beijnen
Identification of two new serum protein profiles for renal cell carcinoma.
Oncology reports 2009;22(2):401-8.
2009: Annelies Jorritsma; Schumacher Ton; John B A G Haanen
Immunotherapeutic strategies: the melanoma example.
Immunotherapy 2009;1(4):679-90.
2009: Gavin M Bendle; John B A G Haanen; Schumacher Ton
Preclinical development of T cell receptor gene therapy.
Current opinion in immunology 2009;21(2):209-14.
2009: Joost H van den Berg; Bastiaan Nujien; Jos H Beijnen; Andrew Vincent; Harm van Tinteren; Jörn Kluge; Leonie A E Woerdeman; Wim E Hennink; Gert Storm; Schumacher Ton; John B A G Haanen
Optimization of intradermal vaccination by DNA tattooing in human skin.
Human gene therapy 2009;20(3):181-9.
2009: S G L Quaak; Bastiaan Nuijen; John B A G Haanen; Jos H Beijnen
Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT.
Journal of pharmaceutical and biomedical analysis 2009;49(2):282-8.
2009: Laura Vroling; Astrid A M van der Veldt; Richard R de Haas; John B A G Haanen; Gerrit Jan Schuurhuis; Dirk J Kuik; Hester van Cruijsen; Hendrik Verheul; Alfons J M van den Eertwegh; Klaas Hoekman; Epie Boven; Victor W M van Hinsbergh; Henk J Broxterman
Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
Angiogenesis 2009;12(1):69-79.
2008: Moniek A de Witte; Annelies Jorritsma; Andrew Kaiser; Marly D van den Boom; Maarten Dokter; Gavin M Bendle; John B A G Haanen; Schumacher Ton
Requirements for effective antitumor responses of TCR transduced T cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(7):5128-36.
2008: S G L Quaak; J H van den Berg; Mireille Toebes; Schumacher Ton; John B A G Haanen; Jos H Beijnen; Bastiaan Nuijen
GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;70(2):429-38.
2008: Hester van Cruijsen; Astrid A M van der Veldt; Laura Vroling; Dinja Oosterhoff; Henk J Broxterman; Rik J Scheper; Giuseppe Giaccone; John B A G Haanen; Alfons J M van den Eertwegh; Epie Boven; Klaas Hoekman; Tanja D de Gruijl
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5884-92.
2008: Astrid A M van der Veldt; Epie Boven; H H Helgason; M van Wouwe; Johannes Berkhof; G de Gast; H Mallo; C N Tillier; Alfons J M van den Eertwegh; John B A G Haanen
Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
British journal of cancer 2008;99(2):259-65.
2008: Barbara G Molenkamp; Berbel J R Sluijter; Paul A M van Leeuwen; Saskia J A M Santegoets; Sybren Meijer; Pepijn G J T B Wijnands; John B A G Haanen; Alfons J M van den Eertwegh; Rik J Scheper; Tanja D de Gruijl
Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4532-42.
2008: L H M Smit; O E Nieweg; W J Mooi; Johannes M G Bonfrer; John B A G Haanen; B B R Kroon; G C De Gast
Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.
Anticancer research 2008;28(4C):2297-302.
2008: Babs E Verstrepen; Adriaan D Bins; Christine Rollier; Petra Mooij; Gerrit Koopman; Neil C Sheppard; Quentin Sattentau; Ralf Wagner; Hans Wolf; Schumacher Ton; Jonathan Luke Heeney; John B A G Haanen
Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates.
Vaccine 2008;26(26):3346-51.
2008: Miriam Coccoris; Erwin Swart; Moniek A de Witte; Jeroen van Heijst; John B A G Haanen; Koen Schepers; Schumacher Ton
Long-term functionality of TCR-transduced T cells in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(10):6536-43.
2008: Moniek A de Witte; Annelies Jorritsma; Erwin Swart; Karin C Straathof; Karin de Punder; John B A G Haanen; Cliona M Rooney; Schumacher Ton
An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(9):6365-73.
2008: Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Axel Bex; Gijsbert de Gast; John B A G Haanen; Epie Boven
Sunitinib for treatment of advanced renal cell cancer: primary tumor response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2431-6.
2008: Annelies Jorritsma; Adriaan D Bins; Schumacher Ton; John B A G Haanen
Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
Cancer research 2008;68(7):2455-62.
2008: Axel Bex; John B A G Haanen; Florry A Vyth-Dreese; Simon Horenblas; Gijsbert C De Gast
Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.
Urologia internationalis 2008;80(4):367-71.
2008: John D Abad; Claudia Wrzensinski; Willem W Overwijk; Moniek A De Witte; Annelies Jorritsma; Cary Hsu; Luca Gattinoni; Cyrille Cohen; Chrystal M Paulos; Douglas Palmer; John B A G Haanen; Schumacher Ton; STEVEN ROSENBERG; Nicholas P Restifo; Richard A Morgan
T-cell receptor gene therapy of established tumors in a murine melanoma model.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(1):1-6.
2007: Annelies Jorritsma; Raquel Gomez-Eerland; Maarten Dokter; Willeke van de Kasteele; Yvonne M Zoet; Ilias Doxiadis; Nathalie Rufer; Pedro Romero; Richard A Morgan; Schumacher Ton; John B A G Haanen
Selecting highly affine and well-expressed TCRs for gene therapy of melanoma.
Blood 2007;110(10):3564-72.
2007: Adriaan Bins; Monika C Wolkers; Marly D van den Boom; John B A G Haanen; Schumacher Ton
In vivo antigen stability affects DNA vaccine immunogenicity.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(4):2126-33.
2007: John B A G Haanen; Schumacher Ton
Vaccine leads to memory loss.
Nature medicine 2007;13(3):248-50.
2007: Adriaan Bins; Henk Mallo; Johan Sein; Colette van den Bogaard; Willem Nooijen; Florry A Vyth-Dreese; Bastiaan Nuijen; Gijsbert C De Gast; John B A G Haanen
Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(2):234-9.
2007: Judith Y M N Engwegen; Niven Mehra; John B A G Haanen; Johannes M G Bonfrer; Jan H M Schellens; Emile E Voest; Jos H Beijnen
Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations.
Laboratory investigation; a journal of technical methods and pathology 2007;87(2):161-72.
2007: Adriaan Bins; Jacco van Rheenen; Kees Jalink; Jonathan R Halstead; Nullin Divecha; David M Spencer; John B A G Haanen; Schumacher Ton
Intravital imaging of fluorescent markers and FRET probes by DNA tattooing.
BMC biotechnology 2007;7():2.
2006: Moniek A de Witte; Miriam Coccoris; Monika C Wolkers; Marly D van den Boom; Elly M Mesman; Ji-Ying Song; Martin van der Valk; John B A G Haanen; Schumacher Ton
Targeting self-antigens through allogeneic TCR gene transfer.
Blood 2006;108(3):870-7.
2006: Ronald Vuylsteke; Barbara G Molenkamp; Paul A M van Leeuwen; Sybren Meijer; Pepijn G J T B Wijnands; John B A G Haanen; Rik J Scheper; Tanja D de Gruijl
Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2826-33.
2006: Willem W Overwijk; Karin E de Visser; Felicia H Tirion; Laurina A de Jong; Thijs W H Pols; Yme U van der Velden; Jasper G van den Boorn; Anna M Keller; Wim A Buurman; Marc R Theoret; Bianca Blom; Nicholas P Restifo; Ada M Kruisbeek; Robert A Kastelein; John B A G Haanen
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(9):5213-22.
2006: John B A G Haanen; Arnold Baars; R Gomez; Pauline Weder; M Smits; Tanja D de Gruijl; B Mary E von Blomberg; Elisabeth Bloemena; Rik J Scheper; SM van Ham; HERBERT PINEDO; Alfons J M van den Eertwegh
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
Cancer immunology, immunotherapy : CII 2006;55(4):451-8.
2006: Florry A Vyth-Dreese; Yeung-Hyen Kim; Trees A M Dellemijn; Ellen Schrama; John B A G Haanen; Eric Spierings; Els Goulmy
In situ visualization of antigen-specific T cells in cryopreserved human tissues.
Journal of immunological methods 2006;310(1-2):78-85.
2006: Mireille Toebes; Miriam Coccoris; Adriaan Bins; Boris Rodenko; Raquel Gomez; Nella J Nieuwkoop; Willeke van de Kasteele; Guus F Rimmelzwaan; John B A G Haanen; Huib Ovaa; Schumacher Ton
Design and use of conditional MHC class I ligands.
Nature medicine 2006;12(2):246-51.
2005: J Martijn Kerst; Axel Bex; Henk Mallo; L G H Dewit; John B A G Haanen; Willem Boogerd; H Jelle Teertstra; Gijsbert C De Gast
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.
Cancer immunology, immunotherapy : CII 2005;54(9):926-31.
2005: Adriaan Bins; Annelies Jorritsma; Monika C Wolkers; Chien-Fu Hung; Tzyy-choou Wu; Schumacher Ton; John B A G Haanen
A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.
Nature medicine 2005;11(8):899-904.
2005: Axel Bex; Henk Mallo; Martijn Kerst; John B A G Haanen; Simon Horenblas; Gijsbert C De Gast
A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor.
Cancer immunology, immunotherapy : CII 2005;54(7):713-9.
2005: Léonie H M Smit; Catharina M Korse; Augustinus A M Hart; Johannes M G Bonfrer; John B A G Haanen; J Martijn Kerst; Omgo E Nieweg; Gijsbert C De Gast
Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.
European journal of cancer (Oxford, England : 1990) 2005;41(3):386-92.
2004: Monique GCT van Oijen; Adriaan Bins; Sjoerd Elias; Johan Sein; Pauline Weder; Gijsbert C De Gast; Henk Mallo; Maarten P W Gallee; Harm van Tinteren; Schumacher Ton; John B A G Haanen
On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4754-60.
2004: Natascha C V Verra; Annelies Jorritsma; Kees Weijer; Janneke J Ruizendaal; Arie Voordouw; Pauline Weder; Erik Hooijberg; Schumacher Ton; John B A G Haanen; Hergen Spits; Rosalie M Luiten
Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.
Cancer research 2004;64(6):2153-61.
2003: Barbara J Johnson; Elaine O Costelloe; David R Fitzpatrick; John B A G Haanen; Schumacher Ton; Lorena E Brown; Anne Kelso
Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2657-62.
2002: Monika C Wolkers; Mireille Toebes; Masaru Okabe; John B A G Haanen; Schumacher Ton
Optimizing the efficacy of epitope-directed DNA vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(10):4998-5004.
2002: Anne M Dickinson; Xiao N Wang; Lisbet Sviland; Florry A Vyth-Dreese; Graham H Jackson; Schumacher Ton; John B A G Haanen; Tuna Mutis; Els Goulmy
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.
Nature medicine 2002;8(4):410-4.
2001: Mariëlle C Haks; Tanina A Cordaro; Jeroen H N van den Brakel; John B A G Haanen; E F de Vries; Jannie Borst; Paul Krimpenfort; Ada M Kruisbeek
A redundant role of the CD3 gamma-immunoreceptor tyrosine-based activation motif in mature T cell function.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(4):2576-88.
2000: John B A G Haanen; Monique GCT van Oijen; Felicia H Tirion; Lauran Oomen; Ada M Kruisbeek; Florry A Vyth-Dreese; Schumacher Ton
In situ detection of virus- and tumor-specific T-cell immunity.
Nature medicine 2000;6(9):1056-60.
2000: Karin E de Visser; Tanina A Cordaro; D Kioussis; John B A G Haanen; Schumacher Ton; Ada M Kruisbeek
Tracing and characterization of the low-avidity self-specific T cell repertoire.
European journal of immunology 2000;30(5):1458-68.
2000: Tanina A Cordaro; Karin E de Visser; Felicia H Tirion; Y M Graus; John B A G Haanen; D Kioussis; Ada M Kruisbeek
Tumor size at the time of adoptive transfer determines whether tumor rejection occurs.
European journal of immunology 2000;30(5):1297-307.
1999: John B A G Haanen; Monika C Wolkers; Ada M Kruisbeek; Schumacher Ton
Selective expansion of cross-reactive CD8(+) memory T cells by viral variants.
The Journal of experimental medicine 1999;190(9):1319-28.
1999: John B A G Haanen; Mireille Toebes; Tanina A Cordaro; Monika C Wolkers; Ada M Kruisbeek; Schumacher Ton
Systemic T cell expansion during localized viral infection.
European journal of immunology 1999;29(4):1168-74.